AstraZeneca gets EU backing for targeted breast cancer therapies
June 27, 2022 at 13:36 PM EDT
Breast cancer patients may now benefit from two of AstraZeneca's existing therapies. The EU has recommended lynparza and enhertu to treat high-risk breast cancer.
